Research on Malignancies in the Context of HIV/AIDS (R01)

archived

This funding opportunity announcement (FOA) issued by NCI and NIDCR, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both AIDS-defining and non-AIDS defining malignancies in diverse populations in the context of an underlying HIV infection. This FOA invites research efforts that will: (i) provide information on the clinical outcomes of such cancers in the HIV-infected population; and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers.

High